KRTL BioTech

Investors keep buying glamorous growth stocks in a bet they are a 'sure thing'

Investors keep buying glamorous growth stocks in a bet they are a 'sure thing'

Mike Santoli breaks down the aggressive buying of "sure things" and shunning of cyclical and policy risk.